xRead - January 2023

692

LOVIN AND GIDLEY

72. Marioni G, Zanoletti E, Lovato A, et al. Relaxin-2 expression in temporal bone carcinoma. Eur Arch Otorhinolaryngol . 2015;272: 3225-3232. 73. Marioni G, Zanoletti E, Mazzoni A, et al. Cortactin and phosphory lated cortactin tyr466 expression in temporal bone carcinoma. Am J Otolaryngol . 2017;38:208-212.

67. Marioni G, Zanoletti E, Stritoni P, et al. Expression of the tumour suppressor maspin in temporal bone carcinoma. Histopathology . 2013; 63(2):242-249. 68. Marioni G, Nucci R, Marino F, et al. Neoangiogenesis in temporal bone carcinoma: the prognostic role of CD105. Otol Neurotol . 2012; 33:843-848. 69. Morita S, Nakamura Y, Homma A, et al. Expression of p53, p16, cyclin D1, epidermal growth factor receptor, and Notch1 in patients with tem poral bone squamous cell carcinoma. Int J Clin Oncol . 2017;22:181-189. 70. Sugimoto H, Ito M, Hatano M, Kondo S, Suzuki S, Yoshizaki T. Roles of epithelial – mesenchymal transition in squamous cell carcinoma of the temporal bone. Otol Neurotol . 2011;32(3):483-487. 71. Marioni G, Nucci R, Marino F, et al. Evaluation of the prognostic role of pSTAT3 expression in temporal bone squamous cell carcinoma. Otol Neurotol . 2013;34(8):1476-1482.

How to cite this article: Lovin BD, Gidley PW. Squamous cell carcinoma of the temporal bone: A current review. Laryngoscope Investigative Otolaryngology . 2019;4:684 – 692. https://doi.org/10.1002/lio2.330